Houston's large and diverse HIV-positive population relies on consistent access to affordable antiretroviral therapy. Tafero EM offers Houston patients and community clinics a WHO-GMP certified generic option at dramatically reduced cost compared to brand pricing.
FAQ: Can Tafero EM be used by women for PrEP, or is it only for men?
Tafero EM (Emtricitabine + TAF) is approved and effective for cisgender men and transgender women who have sex with men for PrEP. However, current guidance notes that TAF-based PrEP has not been as extensively studied for receptive vaginal sex, so cisgender women and others at risk through vaginal exposure are generally advised to use TDF-based PrEP (Emtricitabine + Tenofovir Disoproxil Fumarate) instead, which has more established efficacy data for that route of exposure. Always discuss the right PrEP formulation with your prescribing doctor.
